These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9109183)

  • 21. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A; Buffoli MG; Bussi AR; Doga M; Girelli A; Pizzocolo G; Pozzi A; Wehrenberg WB
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat.
    Makara GB; Kiem DT; Vizi ES
    Eur J Pharmacol; 1995 Dec; 287(1):43-8. PubMed ID: 8666024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.
    Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
    Psychiatry Res; 1988 Sep; 25(3):301-10. PubMed ID: 3141943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone response to clonidine in obsessive-compulsive patients.
    Siever LJ; Insel TR; Jimerson DC; Lake CR; Uhde TW; Aloi J; Murphy DL
    Br J Psychiatry; 1983 Feb; 142():184-7. PubMed ID: 6839074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
    Baumann MH; Milchanowski AB; Rothman RB
    Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
    Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine-induced growth hormone and growth-hormone-releasing hormone release is mediated by tachykinin NK2 receptors in sheep.
    Lemamy GJ; Guillaume V; Ndéboko B; Mouecoucou J; Renard M; Oliver C
    Pharmacology; 2012; 89(5-6):270-4. PubMed ID: 22517235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome.
    Beccaria L; Benzi F; Sanzari A; Bosio L; Brambilla P; Chiumello G
    J Endocrinol Invest; 1996 Nov; 19(10):687-92. PubMed ID: 9007701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
    Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
    Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonidine challenge in childhood anxiety disorder.
    Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
    Hoeck HC; Jakobsen PE; Vestergaard P; Falhof J; Laurberg P
    Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Buffoli MG; Bussi AR; Wehrenberg WB
    Horm Res; 1991; 36(5-6):192-5. PubMed ID: 1823078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined administration of growth-hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs.
    Cella SG; Arce VM; Pieretti F; Locatelli V; Settembrini BP; Müller EE
    Neuroendocrinology; 1993 Mar; 57(3):432-8. PubMed ID: 8321415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1- and 2-adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression.
    Gerra G; Caccavari R; Marcato A; Zaimovic A; Avanzini P; Monica C; Mutti A; Fontanesi B; Delsignore R; Brambilla F
    Acta Psychiatr Scand; 1994 Oct; 90(4):269-73. PubMed ID: 7831997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence.
    Berggren U; Fahlke C; Norrby A; Zachrisson O; Balldin J
    Drug Alcohol Depend; 2000 Jan; 57(3):255-60. PubMed ID: 10661676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone responses to the alpha 2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls.
    Eriksson E; Balldin J; Lindstedt G; Modigh K
    Psychiatry Res; 1988 Oct; 26(1):59-67. PubMed ID: 2907163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.